The upward revision reflects upgrades for China, the IMF said, where it expects policy stimulus to provide support.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...